Cited by 122Substance Abuse Treatment and OutcomesNeurotransmitter Receptor Influence on BehaviorOpioid Use Disorder Treatment

The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.

Pharmacotherapy for Methamphetamine Dependence: A Review of the Pathophysiology of Methamphetamine Addiction and the Theoretical Basis and Efficacy of Pharmacotherapeutic Interventions

Rose, Mark E., Grant, Jon E.·2008·Annals of Clinical Psychiatry

DOI 10.1080/10401230802177656

Open this paper in CoChat — free account

Abstract

BACKGROUND: Methamphetamine (METH) dependence is a significant public health, criminal justice, and social service concern, and although abuse of this drug spans the past 40 years in the U.S., effective treatments have only recently been developed and evaluated. Psychosocial therapies comprise the mainstay of treatment, yet many patients experience ongoing impairments in mood, cognition, emotional control, and motivation, suggesting a role for pharmacotherapy. METHODS: A search of the literature was performed to identify drug therapies utilized with METH dependent patients and the outcome of these trials. RESULTS: With the exception of bupropion, most trials employing direct monoamine agonists yielded negative or inclusive results, a counterintuitive finding. Positive results were produced by a trial of the mixed monoamine agonist/antagonist mirtazapine and by several studies employing indirect dopamine- and glutamate-modulating GABA agonists. Most trials were hampered by high rates of subject attrition, mirroring the difficulty in treating these patients in the outpatient setting. CONCLUSIONS: Although considered preliminary, several therapeutic agents were identified that may prove beneficial in treating METH-dependent patients, including bupropion, mirtazapine, baclofen, and topiramate. Psychosocial therapy remains the cornerstone of treatment, and drug therapy should be regarded as an adjunct, rather than a replacement for psychosocial approaches.

Integrity signals

Registry

Crossref · 10.1080/10401230802177656

Cites

75 of 75 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Mechanisms of neurotransmitter release by amphetamines: A review
Sulzer, D., Sonders, M. S., Poulsen, N. W., & Galli, A. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.04.003 · Cited by 1,243
Association of Dopamine Transporter Reduction With Psychomotor Impairment in Methamphetamine Abusers
Volkow, N. D., Chang, L. L., Wang, G., Fowler, J. S., Leonido–Yee, M., Franceschi, D., Sedler, M. J., Gatley, S. J., HITZEMANN, R. J., Ding, Y. ‐., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.3.377 · Cited by 984
Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin
Rothman, R. B., Baumann, M. H., Dersch, C. M., Romero, D. V., Rice, K. C., Carroll, F. I., & Partilla, J. S. (2000) · Synapse · doi:10.1002/1098-2396(20010101)39:1 · Cited by 944
Substance abuse and violence
Boles, S. M., & Miotto, K. A. (2003) · Aggression and Violent Behavior · doi:10.1016/s1359-1789(01)00057-x · Cited by 666
Neurobiological mechanisms in the transition from drug use to drug dependence
Koob, G. F., Ahmed, S. H., Boutrel, B., Chen, S. A., Kenny, P. J., Markou, A., O’Dell, L. E., Parsons, L. H., & Sanna, P. P. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2003.11.007 · Cited by 598
Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment
Davidson, C., Gow, A. J., Lee, T. H., & Ellinwood, E. H. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00054-6 · Cited by 518
Profiles of Cognitive Dysfunction in Chronic Amphetamine and Heroin Abusers
Ornstein, T. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00097-x · Cited by 445
The need for speed: an update on methamphetamine addiction
Barr, A. M., Panenka, W. J., MacEwan, G. W., Thornton, A. E., Lang, D. J., Honer, W. G., & Lecomte, T. (2006) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0635 · Cited by 441
Compulsive Drug‐Seeking Behavior and Relapse: Neuroadaptation, Stress, and Conditioning Factors
WEISS, F., CICCOCIOPPO, R., PARSONS, L. H., KATNER, S., LIU, X., ZORRILLA, E. P., VALDEZ, G. R., BEN‐SHAHAR, O., ANGELETTI, S., & RICHTER, R. R. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03556.x · Cited by 430
Methamphetamine-Related Psychiatric Symptoms and Reduced Brain Dopamine Transporters Studied With PET
Sekine, Y., Iyo, M., Ouchi, Y., Matsunaga, T., Tsukada, H., Okada, H., Yoshikawa, E., Futatsubashi, M., Takei, N., & Mori, N. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.8.1206 · Cited by 408
Implications of Chronic Methamphetamine Use: A Literature Review
Meredith, C. W., Jaffe, C., Ang-Lee, K., & Saxon, A. J. (2005) · Harvard Review of Psychiatry · doi:10.1080/10673220591003605 · Cited by 396
Mood Disturbances and Regional Cerebral Metabolic Abnormalities inRecently Abstinent Methamphetamine Abusers
London, E. D., Simon, S. L., Berman, S. M., Mandelkern, M. A., Lichtman, A. M., Bramen, J. E., Shinn, A. K., Miotto, K. A., Learn, J. E., Dong, Y., et al. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.1.73 · Cited by 390
Evidence for long-term neurotoxicity associated with methamphetamine abuse
Ernst, T., Chang, L., Leonido–Yee, M., & Speck, O. (2000) · Neurology · doi:10.1212/wnl.54.6.1344 · Cited by 373
Effect of Prize-Based Incentives on Outcomes in Stimulant Abusers in Outpatient Psychosocial Treatment Programs
Petry, N. M., Peirce, J. M., Stitzer, M. L., BLAINE, J. D., Roll, J. M., Cohen, A. J., Obert, J. L., Killeen, T. K., Saladin, M. E., Cowell, M., et al. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.10.1148 · Cited by 373
Neuropsychological Effects of Chronic Methamphetamine Use on Neurotransmitters and Cognition: A Review
NORDAHL, T. E., Salo, R. E., & Leamon, M. H. (2003) · Journal of Neuropsychiatry · doi:10.1176/jnp.15.3.317 · Cited by 372
The Role of the Striatopallidal and Extended Amygdala Systems in Drug Addiction
Koob, G. F. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09282.x · Cited by 322
Neurobiology of Addiction: Toward the Development of New Therapies
Koob, G. F. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06682.x · Cited by 318
Behavioral treatment approaches for methamphetamine dependence and HIV-related sexual risk behaviors among urban gay and bisexual men
Shoptaw, S., Reback, C. J., Peck, J. A., Yang, X., Rotheram-Fuller, E., Larkins, S., Veniegas, R. C., Freese, T. E., & Hucks-Ortiz, C. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.10.004 · Cited by 313
Escalated aggressive behavior: Dopamine, serotonin and GABA
de Almeida, R. M. M., Ferrari, P. F., Parmigiani, S., & Miczek, K. A. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.10.004 · Cited by 303
Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis
CHEN, C.-K., LIN, S.-K., SHAM, P. C., BALL, D., LOH, E.-W., HSIAO, C.-C., CHIANG, Y.-L., REE, S.-C., LEE, C.-H., & MURRAY, R. M. (2003) · Psychological Medicine · doi:10.1017/s0033291703008353 · Cited by 295
Brain Serotonin Transporter Density and Aggression in Abstinent Methamphetamine Abusers
Sekine, Y., Ouchi, Y., Takei, N., Yoshikawa, E., Nakamura, K., Futatsubashi, M., Okada, H., Minabe, Y., Suzuki, K., Iwata, Y., et al. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.1.90 · Cited by 293
Methamphetamine Dependence Is Associated With Neurocognitive Impairment in the Initial Phases of Abstinence
Kalechstein, A. D., Newton, T. F., & Green, M. M. (2003) · Journal of Neuropsychiatry · doi:10.1176/jnp.15.2.215 · Cited by 290
Speed kills: cellular and molecular bases of methamphetamine‐induced nerve terminal degeneration and neuronal apoptosis
Cadet, J. L., Jayanthi, S., & Deng, X. (2003) · The FASEB Journal · doi:10.1096/fj.03-0073rev · Cited by 286
Neuroadaptive mechanisms of addiction: studies on the extended amygdala
Koob, G. F. (2003) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2003.08.005 · Cited by 285
Behavioral and Functional Neuroimaging Evidence for Prefrontal Dysfunction in Methamphetamine-Dependent Subjects
Paulus, M. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00334-7 · Cited by 283
Violence and Serotonin: Influence of Impulse Control, Affect Regulation, and Social Functioning
KRAKOWSKI, M. I. (2003) · Journal of Neuropsychiatry · doi:10.1176/jnp.15.3.294 · Cited by 246
Smaller subcortical volumes and cognitive deficits in children with prenatal methamphetamine exposure
Chang, L., Smith, L. M., LoPresti, C. M., Yonekura, M. L., Kuo, J., Walot, I., & Ernst, T. M. (2004) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2004.06.004 · Cited by 243
Partial Recovery of Brain Metabolism in Methamphetamine Abusers After Protracted Abstinence
Wang, G., Volkow, N. D., Chang, L. L., Miller, E. N., Sedler, M. J., HITZEMANN, R. J., Zhu, W., Logan, J., Ma, Y., & Fowler, J. S. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.2.242 · Cited by 241
From genes to aggressive behavior: the role of serotonergic system
Popova, N. K. (2006) · BioEssays · doi:10.1002/bies.20412 · Cited by 236
Methamphetamine Abstinence Syndrome: Preliminary Findings
Newton, T. F., Kalechstein, A. D., Duran, S., Vansluis, N., & Ling, W. W. (2004) · American Journal on Addictions · doi:10.1080/10550490490459915 · Cited by 220
The methamphetamine epidemic: Implications for HIV prevention and treatment
Colfax, G., & Shoptaw, S. (2005) · Current HIV/AIDS Reports · doi:10.1007/s11904-005-0016-4 · Cited by 219
Treatment of methamphetamine abuse: research findings and clinical directions
Cretzmeyer, M., Vaughan‐Sarrazin, M., Huber, D. L., Block, R. I., & Hall, J. A. (2003) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(03)00028-x · Cited by 196
Contingency Management for the Treatment of Methamphetamine Use Disorders
Roll, J. M., Petry, N. M., Stitzer, M. L., Brecht, M. L., Peirce, J. M., McCann, M., BLAINE, J. D., Macdonald, M. J., DiMaria, J., Lucero, L., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1993 · Cited by 196
Contingency Management for the Treatment of Methamphetamine Use Disorders
Roll, J. M., Petry, N. M., Stitzer, M. L., Brecht, M. L., Peirce, J. M., McCann, M. J., Blaine, J., MacDonald, M., DiMaria, J., Lucero, L., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.11.1993 · Cited by 196
Patterns of Methamphetamine Abuse and Their Consequences
Cho, A. K., & Melega, W. P. (2001) · Journal of Addictive Diseases · doi:10.1300/j069v21n01_03 · Cited by 166
Bupropion Reduces Methamphetamine-Induced Subjective Effects and Cue-Induced Craving
Newton, T. F., Roache, J. D., Garza, R. D. L., FONG, T. W., Wallace, C. L., Li, S.-H., Elkashef, A. M., Chiang, N., & Kahn, R. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300979 · Cited by 163
Methamphetamine Use, Self-Reported Violent Crime, and Recidivism Among Offenders in California Who Abuse Substances
Cartier, J., Farabee, D. J., & PRENDERGAST, M. L. (2006) · Journal of Interpersonal Violence · doi:10.1177/0886260505285724 · Cited by 154
Stimulant Psychosis: Symptom Profile and Acute Clinical Course
Harris, D. S., & Batki, S. L. (2000) · American Journal on Addictions · doi:10.1080/10550490050172209 · Cited by 153
Randomized, placebo-controlled trial of sertraline and contingency management for the treatment of methamphetamine dependence
SHOPTAW, S. J., Huber, A., Peck, J. A., Yang, X., Liu, J., Dang, J., Roll, J. M., Shapiro, B., Rotheram-Fuller, E. J., & Ling, W. W. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.03.005 · Cited by 146
The effect of relapse on cognition in abstinent methamphetamine abusers
Simon, S. L., Dacey, J., Glynn, S., Rawson, R., & Ling, W. (2004) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2004.03.011 · Cited by 142
The effects of acute haloperidol or risperidone on subjective responses to methamphetamine in healthy volunteers
Wachtel, S. R., Ortengren, A., & Wit, H. D. (2002) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(02)00104-7 · Cited by 138
Cerebral metabolic dysfunction and impaired vigilance in recently abstinent methamphetamine abusers
London, E. D., Berman, S. M., Voytek, B., Simon, S. L., Mandelkern, M. A., Monterosso, J., Thompson, P. M., Brody, A. L., Geaga, J. A., Hong, M. S., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.04.039 · Cited by 136
Amphetamine Withdrawal: I. Reliability, Validity and Factor Structure of a Measure
Srisurapanont, M., Jarusuraisin, N., & Jittiwutikan, J. (1999) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.1999.00517.x · Cited by 125
Increased self-administration of d-amphetamine after destruction of 5-hydroxytryptaminergic neurons
Lyness, W. H., Friedle, N. M., & Moore, K. E. (1980) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(80)90456-6 · Cited by 122
Safety and efficacy of ?-vinyl GABA (GVG) for the treatment of methamphetamine and/or cocaine addiction
Brodie, J. D., Figueroa, E., LASKA, E. M., & Dewey, S. L. (2004) · Synapse · doi:10.1002/syn.20097 · Cited by 121
Deficient Strategic Control of Verbal Encoding and Retrieval in Individuals With Methamphetamine Dependence.
Woods, S. P., Rippeth, J. D., Conover, E., Gongvatana, A., González, R., Carey, C. L., Cherner, M., Heaton, R. K., & Grant, I. (2005) · Neuropsychology · doi:10.1037/0894-4105.19.1.35 · Cited by 120
Methamphetamine Users in Sustained Abstinence
NORDAHL, T. E., Salo, R. E., Natsuaki, Y., Galloway, G. P., Waters, C., Moore, C. D., Kile, S. J., & Buonocore, M. H. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.4.444 · Cited by 110
Randomized, placebo-controlled trial of baclofen and gabapentin for the treatment of methamphetamine dependence
Heinzerling, K. G., SHOPTAW, S. J., Peck, J. A., Yang, X., Liu, J., Roll, J. M., & Ling, W. W. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.03.019 · Cited by 102
Potential benefits of quetiapine in the treatment of substance dependence disorders
Sattar, S. P., Bhatia, S. C., & Petty, F. (2004) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0444 · Cited by 93
Drug addiction: Functional neurotoxicity of the brain reward systems
Weiss, F., & Koob, G. F. (2001) · Neurotoxicity Research · doi:10.1007/bf03033235 · Cited by 86
Status of Methamphetamine Users 2–5 Years After Outpatient Treatment
Rawson, R. A., Huber, A., Brethen, P., Obert, J. L., Gulati, V., SHOPTAW, S. J., & Ling, W. W. (2001) · Journal of Addictive Diseases · doi:10.1300/j069v21n01_09 · Cited by 84
Meth mouth: a review of methamphetamine abuse and its oral manifestations.
Curtis, E. K. (2006) · PubMed · Cited by 84
Increased white matter hyperintensities in male methamphetamine abusers
Bae, S. C., Lyoo, I. K., Sung, Y. H., Yoo, J., Chung, A., Yoon, S. J., Kim, D., Hwang, J., Kim, S. J., & Renshaw, P. F. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.05.016 · Cited by 80
Methamphetamine use and Violence
Sommers, I. B., & Baskin, D. R. (2006) · Journal of Drug Issues · doi:10.1177/002204260603600104 · Cited by 80
A controlled trial of imipramine for the treatment of methamphetamine dependence
Galloway, G. P., Newmeyer, J. A., Knapp, T., Stalcup, S. A., & Smith, D. E. (1996) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(96)00154-7 · Cited by 71
Clinical Effects and Management of Methamphetamine Abuse
Romanelli, F., & Smith, K. M. (2006) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.26.8.1148 · Cited by 69
Amphetamines: An Update on Forensic Issues
Logan, B. K. (2001) · Journal of Analytical Toxicology · doi:10.1093/jat/25.5.400 · Cited by 60
Mirtazapine in amphetamine detoxification: a placebo-controlled pilot study
Kongsakon, R., Papadopoulos, K. I., & Saguansiritham, R. (2005) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000166815.83017.d8 · Cited by 53
Methamphetamine Abuse: Issues for Special Populations
Freese, T. E., Obert, J. L., Dickow, A., Cohen, J. B., & Lord, R. H. (2000) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2000.10400226 · Cited by 52
Effects of acute topiramate dosing on methamphetamine-induced subjective mood
Johnson, B. A., Roache, J. D., Ait‐Daoud, N., Wells, L. T., Wallace, C. L., Dawes, M. A., Liu, L., & Wang, X. (2006) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705006401 · Cited by 52
Short-term Treatment of Cocaine and/or Methamphetamine Abuse With Vigabatrin
Fechtner, R. D. (2006) · Archives of Ophthalmology · doi:10.1001/archopht.124.9.1257 · Cited by 46
Fatal Amphetamine-Associated Cardiotoxicity and Its Medicolegal Implications
Jacobs, W. (2006) · American Journal of Forensic Medicine & Pathology · doi:10.1097/01.paf.0000188082.68009.10 · Cited by 45
Pharmacotherapies for problematic psychostimulant use: a review of current research
Shearer, J., & Gowing, L. (2004) · Drug and Alcohol Review · doi:10.1080/09595230410001704190 · Cited by 44
Alcohol and violence and the possible role of serotonin
Badawy, A. A. ‐. (2003) · Criminal Behaviour and Mental Health · doi:10.1002/cbm.529 · Cited by 40
Effects of topiramate on methamphetamine-induced changes in attentional and perceptual-motor skills of cognition in recently abstinent methamphetamine-dependent individuals
Johnson, B. A., Roache, J. D., Ait‐Daoud, N., Wells, L. T., Wallace, C. L., Dawes, M. A., Liu, L., & Wang, X. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.08.002 · Cited by 38
An Exploratory Study: The Use of Paroxetine for Methamphetamine Craving
Piasecki, M. P., Steinagel, G. M., Thienhaus, O. J., & Kohlenberg, B. S. (2002) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2002.10399967 · Cited by 35
Substitution therapy for amphetamine users
Shearer, J., Sherman, J. P., WODAK, A. D., & van Beek, I. (2002) · Drug and Alcohol Review · doi:10.1080/09595230220139082 · Cited by 35
Depression and other psychological health problems among methamphetamine dependent patients in treatment: Implications for assessment and treatment outcome
Dyer, K. D., & Cruickshank, C. (2005) · Australian Psychologist · doi:10.1080/00050060500094647 · Cited by 32
Psychostimulants and Vesicle Trafficking: A Novel Mechanism and Therapeutic Implications
Hanson, G. R., Sandoval, V., Riddle, E. L., & Fleckenstein, A. E. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1316.019 · Cited by 31
Methamphetamine Quantitative Urine Concentrations during a Controlled Trial of Fluoxetine Treatment: Preliminary Analysis
Batki, S. L., MOON, J., Delucchi, K., Bradley, M. S., HERSH, D., Smolar, S., Mengis, M. M., LEFKOWITZ, E., SEXE, D., MORELLO, L., et al. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06688.x · Cited by 21
The treatment of stimulant dependence
Schuckit, M. A. (1994) · Addiction · doi:10.1111/j.1360-0443.1994.tb03758.x · Cited by 21
Improvement in measures of psychological distress amongst amphetamine misusers treated with brief cognitive–behavioural therapy (CBT)
Feeney, G. F. X., Connor, J. P., Young, R. M., Tucker, J., & McPherson, A. (2006) · Addictive Behaviors · doi:10.1016/j.addbeh.2005.12.026 · Cited by 20
Methylphenidate effective in treating amphetamine abusers with no other psychiatric disorder
Laqueille, X., Dervaux, A., Omari, F. E., Kanit, M., & Bayle, F. (2005) · European Psychiatry · doi:10.1016/j.eurpsy.2005.03.013 · Cited by 16
Kinetic and cardiovascular effects of acute topiramate dosing among non-treatment-seeking, methamphetamine-dependent individuals
Johnson, B. A., Wells, L. T., Roache, J. D., Wallace, C. L., Ait‐Daoud, N., Dawes, M. A., Liu, L., Wang, X., & Javors, M. A. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.11.011 · Cited by 9
Treatment of Methamphetamine Cravings With Bupropion
Berigan, T. R. (2001) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.v03n0603b · Cited by 8

Sorted by citations

Methamphetamine: An update on epidemiology, pharmacology, clinical phenomenology, and treatment literature
Courtney, K. E., & Ray, L. A. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.08.003 · Cited by 502
Methamphetamine use: A comprehensive review of molecular, preclinical and clinical findings
Panenka, W. J., Procyshyn, R. M., Lecomte, T., MacEwan, G. W., Flynn, S. W., Honer, W. G., & Barr, A. M. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.11.016 · Cited by 432
Methamphetamine use causes cognitive impairment and altered decision-making
Mizoguchi, H., & Yamada, K. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2018.12.019 · Cited by 154
Oxytocin decreases methamphetamine self-administration, methamphetamine hyperactivity, and relapse to methamphetamine-seeking behaviour in rats
Carson, D. S., Cornish, J. L., Guastella, A. J., Hunt, G. E., & McGregor, I. S. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.06.018 · Cited by 146
Topiramate for the Treatment of Cocaine Addiction: A Randomized Clinical Trial
Johnson, B. A., Ait-Daoud, N., Wang, X.-Q., Penberthy, J. K., Javors, M. A., Seneviratne, C., & Liu, L. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.2295 · Cited by 133

See all 122

Authors: Rose, M. E., & Grant, J. E.
Affiliations: University of Minnesota (US)
ORCID: Grant, Jon E.
Venue: Annals of Clinical Psychiatry
Publisher: SAGE Publications
Published: 2008-08
Volume: 20
Issue: 3
Pages: 145-155
ISSN: 1040-1237 (ISSN-L)
1547-3325
DOI: 10.1080/10401230802177656
OpenAlex: W2123983203
Cited by: 121
References: 74
Citations by year: 2026: 1 · 2025: 3 · 2024: 4 · 2023: 2 · 2022: 3 · 2021: 4 · 2020: 3 · 2019: 42 · 2018: 2 · 2017: 3 · 2016: 8 · 2015: 5 · 2014: 4 · 2013: 5 · 2012: 4
FWCI: 7.14
Type: journal article
Language: en
Open access: closed
Locations: Annals of Clinical Psychiatry (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
Keywords: methamphetamine dependence, pharmacotherapy, bupropion, mirtazapine, baclofen, topiramate, GABA agonists, dopaminergic modulation, glutamate modulation, treatment discontinuation, psychosocial interventions, adjunctive therapy
MeSH terms: Amygdala, Central Nervous System Stimulants, Chronic Disease, Humans, Methamphetamine, Nucleus Accumbens, Recurrence, Neurotransmitter Agents, Amphetamine-Related Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Pharmacotherapy for Methamphetamine Dependence: A Review of the Pathophysiology of Methamphetamine Addiction and the Theoretical Basis and Efficacy of Pharmacotherapeutic Interventions

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks